NCT00003185View on ClinicalTrials.gov

Biological Therapy in Treating Patients With Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 1997

Study Completion Date

July 31, 1998

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

autologous tumor cell vaccine

BIOLOGICAL

sargramostim

BIOLOGICAL

tumor-draining lymph node lymphocyte therapy

DRUG

cyclophosphamide

PROCEDURE

conventional surgery

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

The Cleveland Clinic

OTHER

NCT00003185 - Biological Therapy in Treating Patients With Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter